Echo IQ Limited (ASX:EIQ)

Andrew Grover brings 25 years’ experience in growing successful businesses across a diverse range of industries. As a founder and investor in numerous innovative companies, his businesses have been featured in BRW Fast 100 and Deloitte’s Fast 50 over several years.

Steven Formica brings to the company significant business management and development experience. He has led a number of privately held business ventures across multiple industry sectors. Mr. Formica is currently the non-executive chairman of ASX listed Ragnar Metals (ASX:RAG), non-executive chairman of ASX listed Albion Resources Ltd (ASX: ALB), non-executive chairman of ASX listed Kaiser Reef Limited (ASX: KAU), non-executive director of ASX listed Bindi Metals (ASX:BIM), non-executive director of ASX Listed Great Northern Minerals Limited (ASX: GNM), and a successful investor in a number of ASX listed entities. Mr. Formica has previously held directorships with ASX listed companies Jade Gas Holdings (ASX:JGH), Labyrinth Resources Ltd (ASX: LRL), Bowen Coking Coal Ltd (ASX: BCB) and Lindian Resources Limited (ASX:LIN).

Steve Picton is an experienced Board Director and business leader. As CEO of mobile virtual network operator goTalk Limited, he increased revenues to more than $100M. Mr. Picton holds a Bachelor of Science in technology and a Master of Science (Business) from London Business School and is both a Chartered Engineer and a Member of The Institute of Company Directors. He is also a Sloan Fellow which was awarded to him in 1993 by the Sloan Foundation as part of the joint MIT, Stanford and LBS programme. Mr Picton is currently the non-executive chairman of ASX listed FlexiRoam Ltd (ASX: FRX).

Ken Nelson is a leading US-based medical technology and healthcare executive with over 20 years’ industry experience. During his career he has been pivotal in leading successful commercialisation efforts with multiple cardiac-focused digital health companies including remote cardiac and diagnostics monitoring business, BioTelemetry, wearable device company, iRhythm and ambulatory ECG solutions monitoring group, Bardy Diagnostics. Currently, he serves as partner in the Medtech Advantage Fund, which has an exclusive partnership with Medtech Innovator, the largest medical technology and digital health startup accelerator globally.

Jessamyn (Jess) Lyons is a Chartered Secretary, a Fellow of the Governance Institute of Australia and holds a Bachelor of Commerce from the University of Western Australia with majors in Investment Finance, Corporate Finance and Marketing. Jess is a highly experienced Company Secretary and has held positions with Macquarie Bank, UBS (London) and Patersons Securities.

Ken Nelson is a leading US-based medical technology and healthcare executive with over 20 years’ industry experience. During his career he has been pivotal in leading successful commercialisation efforts with multiple cardiac-focused digital health companies including remote cardiac and diagnostics monitoring business, BioTelemetry, wearable device company, iRhythm and ambulatory ECG solutions monitoring group, Bardy Diagnostics. Currently, he serves as partner in the Medtech Advantage Fund, which has an exclusive partnership with Medtech Innovator (www.medtechinnovator.org), the largest medical technology and digital health startup accelerator globally.   In addition to this, Ken serves as Chairman to the Board of Israeli-based medical technology company, CardiaCare, and is an active Board member of other cardiac-focused digital health and medical technology companies including HeartBeam (NASDAQ: BEAT), Acarix (NASDAQ: ACARIX), US-based company Epitel, and European-based platform Happitech. Ken also sits on a number of advisory boards and planning committees for early-stage medical technology companies, as well as several industry groups including the Innovation Advisory Board of Heart Rhythm Society, the Health Tech Innovation Business Advisory Board and the Heart & Brain Accelerator of the American Heart Association.